OTCQB: IGXT | TSX-V: IGX

SAINT LAURENT, QUEBEC, Jan. 5, 2012 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCBB:IGXT) ("IntelGenx") today announced that Dr. Horst Zerbe, the Company's President and CEO, will be presenting at Biotech Showcase 2012 to be held on January 9-11, 2012 at the Parc 55 Wyndham – Union Square in San Francisco, California. Biotech Showcase is a parallel symposium to the 30th Annual J.P. Morgan Healthcare Conference in San Francisco.

IntelGenx' presentation is scheduled to commence on Monday, January 9, at 10.30 A.M. Pacific Time in the Mission 1 Room of Parc 55 Wyndham. Dr. Zerbe's presentation will be posted on the Company's website following the presentation.

A live webcast of the presentation will be available at:
http://www.media-server.com/m/p/2ai252x7

About IntelGenx:
IntelGenx is a drug delivery company focused on the development of oral controlled-release products as well as novel rapidly disintegrating delivery systems. IntelGenx uses its unique multiple layer delivery system to provide zero-order release of active drugs in the gastrointestinal tract. IntelGenx has also developed novel delivery technologies for the rapid delivery of pharmaceutically active substances in the oral cavity based on its experience with rapidly disintegrating films. IntelGenx' research and development pipeline includes products for the treatment of severe depression, hypertension, erectile dysfunction, benign prostatic hyperplasia, migraine, insomnia, bipolar disorder, idiopathic pulmonary fibrosis, allergies and pain management. More information is available about the company at www.intelgenx.com.
Each of the TSX Venture Exchange and OTC Bulletin Board has neither approved nor disapproved the contents of this press release.

CONTACT:

Dr. Horst G. Zerbe,
President and CEO
IntelGenx Technologies Corp.
T: +1 514-331-7440 (ext. 201)
F: +1 514-331-0436
This email address is being protected from spambots. You need JavaScript enabled to view it.
www.intelgenx.com